GHO Capital, an investor in global healthcare, agreed to acquire Genesis Research, a provider of tech-enabled Real-World Evidence and Health Economics and Outcomes Research services. Financial terms were not disclosed. “We are extremely excited by this partnership and the opportunity to pursue our strategic priorities as well as scale our holistic, cross-functional engagement. GHO is a strong partner with healthcare expertise to accelerate our growth and expand our global footprint, which will in turn strengthen the capabilities across the sector leading to better healthcare outcomes. We’d also like to thank our first equity partner, Rallyday, for supporting our inspired vision,” Frank A. Corvino, Genesis Research CEO.